REVEAL puts leukocytes into risk stratification
In this issue of Blood, Gerds et al identified persistent leukocytosis above the upper normal value as a risk factor for thrombosis in polycythemia vera. F
In this issue of Blood, Gerds et al identified persistent leukocytosis above the upper normal value as a risk factor for thrombosis in polycythemia vera. F
Treatment with autologous HER2-specifc CAR T cells was considered tolerable and produced responses in a phase 1 trial of patients with advanced sarcoma.
Liposomal irinotecan produced similar survival results as topotecan when used as second-line therapy in patients with SCLC.
After noticing a lump on the side of his neck, Judd Woehrle came to MD Anderson for oropharyngeal cancer treatment. Here’s how robotic surgery and…
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
The phase III RESILIENT Part 2 trial has shown no overall survival benefit with second-line liposomal irinotecan vs topotecan in patients with small cell lung…
Altering or increasing the dosage of smoking cessation regimens may help patients quit smoking, according to results from a recent sequential multiple-assignment randomized trial.
Brain and Other Nervous System Cancer statistics
Lucia Masarova, MD, PhD, elaborated on the latest updates across myeloproliferative neoplasms, focusing on significant studies and emerging therapeutic approaches.
Neal Shore, MD, FACS, discusses the importance of a multidisciplinary team in light of recent developments in urologic oncology.